STAT3 and ovarian neoplasm: Furthermore, we identified that compared with the vehicle treatment, BBI608 (a potent small‐molecule inhibitor of Stat3) reduced the expression of the proliferation marker Ki67 and increased the expression of cleaved caspase‐3 in tumour cells by inhibiting Stat3 activation in ovarian tumour cells.